nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—SLC6A4—chronic obstructive pulmonary disease	0.375	1	CbGaD
Venlafaxine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.039	0.101	CbGbCtD
Venlafaxine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.039	0.101	CbGbCtD
Venlafaxine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0324	0.0842	CbGbCtD
Venlafaxine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0324	0.0842	CbGbCtD
Venlafaxine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0296	0.077	CbGbCtD
Venlafaxine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0296	0.077	CbGbCtD
Venlafaxine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0264	0.0686	CbGbCtD
Venlafaxine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0249	0.0646	CbGbCtD
Venlafaxine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0245	0.0638	CbGbCtD
Venlafaxine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0168	0.0436	CbGbCtD
Venlafaxine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0164	0.0425	CbGbCtD
Venlafaxine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.016	0.0416	CbGbCtD
Venlafaxine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0143	0.0371	CbGbCtD
Venlafaxine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.014	0.0363	CbGbCtD
Venlafaxine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0132	0.0343	CbGbCtD
Venlafaxine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00838	0.0218	CbGbCtD
Venlafaxine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00791	0.0206	CbGbCtD
Venlafaxine—Desvenlafaxine—SLC6A4—chronic obstructive pulmonary disease	0.00237	0.627	CrCbGaD
Venlafaxine—Tramadol—SLC6A4—chronic obstructive pulmonary disease	0.00141	0.373	CrCbGaD
Venlafaxine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000587	CcSEcCtD
Venlafaxine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000587	CcSEcCtD
Venlafaxine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000585	CcSEcCtD
Venlafaxine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000585	CcSEcCtD
Venlafaxine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000585	CcSEcCtD
Venlafaxine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000111	0.000582	CcSEcCtD
Venlafaxine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000579	CcSEcCtD
Venlafaxine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000579	CcSEcCtD
Venlafaxine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000577	CcSEcCtD
Venlafaxine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000577	CcSEcCtD
Venlafaxine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00057	CcSEcCtD
Venlafaxine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000568	CcSEcCtD
Venlafaxine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000568	CcSEcCtD
Venlafaxine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000564	CcSEcCtD
Venlafaxine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000562	CcSEcCtD
Venlafaxine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000562	CcSEcCtD
Venlafaxine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000562	CcSEcCtD
Venlafaxine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000106	0.000559	CcSEcCtD
Venlafaxine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000559	CcSEcCtD
Venlafaxine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000556	CcSEcCtD
Venlafaxine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000554	CcSEcCtD
Venlafaxine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000554	CcSEcCtD
Venlafaxine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000104	0.000549	CcSEcCtD
Venlafaxine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.000549	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000548	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000548	CcSEcCtD
Venlafaxine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000544	CcSEcCtD
Venlafaxine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000544	CcSEcCtD
Venlafaxine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000541	CcSEcCtD
Venlafaxine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000103	0.000541	CcSEcCtD
Venlafaxine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000538	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000537	CcSEcCtD
Venlafaxine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000536	CcSEcCtD
Venlafaxine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000536	CcSEcCtD
Venlafaxine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000535	CcSEcCtD
Venlafaxine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000535	CcSEcCtD
Venlafaxine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000533	CcSEcCtD
Venlafaxine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000531	CcSEcCtD
Venlafaxine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000531	CcSEcCtD
Venlafaxine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000529	CcSEcCtD
Venlafaxine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000529	CcSEcCtD
Venlafaxine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.0001	0.000529	CcSEcCtD
Venlafaxine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0001	0.000527	CcSEcCtD
Venlafaxine—Injury—Prednisone—chronic obstructive pulmonary disease	9.95e-05	0.000524	CcSEcCtD
Venlafaxine—Somnolence—Montelukast—chronic obstructive pulmonary disease	9.95e-05	0.000524	CcSEcCtD
Venlafaxine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	9.92e-05	0.000523	CcSEcCtD
Venlafaxine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	9.9e-05	0.000521	CcSEcCtD
Venlafaxine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	9.85e-05	0.000519	CcSEcCtD
Venlafaxine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	9.85e-05	0.000519	CcSEcCtD
Venlafaxine—Fatigue—Formoterol—chronic obstructive pulmonary disease	9.85e-05	0.000519	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	9.83e-05	0.000517	CcSEcCtD
Venlafaxine—Constipation—Formoterol—chronic obstructive pulmonary disease	9.77e-05	0.000514	CcSEcCtD
Venlafaxine—Pain—Arformoterol—chronic obstructive pulmonary disease	9.77e-05	0.000514	CcSEcCtD
Venlafaxine—Pain—Formoterol—chronic obstructive pulmonary disease	9.77e-05	0.000514	CcSEcCtD
Venlafaxine—Constipation—Arformoterol—chronic obstructive pulmonary disease	9.77e-05	0.000514	CcSEcCtD
Venlafaxine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	9.75e-05	0.000514	CcSEcCtD
Venlafaxine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	9.73e-05	0.000513	CcSEcCtD
Venlafaxine—Amnesia—Prednisone—chronic obstructive pulmonary disease	9.73e-05	0.000513	CcSEcCtD
Venlafaxine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	9.68e-05	0.00051	CcSEcCtD
Venlafaxine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	9.65e-05	0.00209	CbGpPWpGaD
Venlafaxine—Fatigue—Montelukast—chronic obstructive pulmonary disease	9.65e-05	0.000508	CcSEcCtD
Venlafaxine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	9.62e-05	0.000506	CcSEcCtD
Venlafaxine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.59e-05	0.00207	CbGpPWpGaD
Venlafaxine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	9.59e-05	0.000505	CcSEcCtD
Venlafaxine—SLC6A3—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	9.58e-05	0.00207	CbGpPWpGaD
Venlafaxine—Pain—Montelukast—chronic obstructive pulmonary disease	9.57e-05	0.000504	CcSEcCtD
Venlafaxine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	9.56e-05	0.000503	CcSEcCtD
Venlafaxine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	9.54e-05	0.000502	CcSEcCtD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	9.54e-05	0.00206	CbGpPWpGaD
Venlafaxine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	9.51e-05	0.000501	CcSEcCtD
Venlafaxine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	9.51e-05	0.000501	CcSEcCtD
Venlafaxine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	9.49e-05	0.0005	CcSEcCtD
Venlafaxine—Purpura—Prednisone—chronic obstructive pulmonary disease	9.49e-05	0.0005	CcSEcCtD
Venlafaxine—Rash—Aminophylline—chronic obstructive pulmonary disease	9.46e-05	0.000498	CcSEcCtD
Venlafaxine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	9.45e-05	0.000498	CcSEcCtD
Venlafaxine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	9.43e-05	0.000496	CcSEcCtD
Venlafaxine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.42e-05	0.00204	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	9.41e-05	0.000496	CcSEcCtD
Venlafaxine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	9.41e-05	0.000496	CcSEcCtD
Venlafaxine—Headache—Aminophylline—chronic obstructive pulmonary disease	9.4e-05	0.000495	CcSEcCtD
Venlafaxine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	9.38e-05	0.000494	CcSEcCtD
Venlafaxine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	9.36e-05	0.000493	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	9.34e-05	0.000492	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	9.34e-05	0.000492	CcSEcCtD
Venlafaxine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.3e-05	0.00201	CbGpPWpGaD
Venlafaxine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	9.3e-05	0.00049	CcSEcCtD
Venlafaxine—Pain—Salbutamol—chronic obstructive pulmonary disease	9.22e-05	0.000486	CcSEcCtD
Venlafaxine—Constipation—Salbutamol—chronic obstructive pulmonary disease	9.22e-05	0.000486	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	9.15e-05	0.000482	CcSEcCtD
Venlafaxine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.000482	CcSEcCtD
Venlafaxine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.000482	CcSEcCtD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	9.1e-05	0.00197	CbGpPWpGaD
Venlafaxine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.07e-05	0.000478	CcSEcCtD
Venlafaxine—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.07e-05	0.000478	CcSEcCtD
Venlafaxine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	9.03e-05	0.000475	CcSEcCtD
Venlafaxine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	9.03e-05	0.000475	CcSEcCtD
Venlafaxine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	9.03e-05	0.000475	CcSEcCtD
Venlafaxine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	9.03e-05	0.000475	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.01e-05	0.00195	CbGpPWpGaD
Venlafaxine—Affect lability—Prednisone—chronic obstructive pulmonary disease	9e-05	0.000474	CcSEcCtD
Venlafaxine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	9e-05	0.000474	CcSEcCtD
Venlafaxine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	8.93e-05	0.00047	CcSEcCtD
Venlafaxine—Rash—Tiotropium—chronic obstructive pulmonary disease	8.92e-05	0.00047	CcSEcCtD
Venlafaxine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	8.92e-05	0.000469	CcSEcCtD
Venlafaxine—Nausea—Aminophylline—chronic obstructive pulmonary disease	8.91e-05	0.000469	CcSEcCtD
Venlafaxine—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.89e-05	0.00192	CbGpPWpGaD
Venlafaxine—Urticaria—Montelukast—chronic obstructive pulmonary disease	8.89e-05	0.000468	CcSEcCtD
Venlafaxine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	8.89e-05	0.000468	CcSEcCtD
Venlafaxine—Headache—Tiotropium—chronic obstructive pulmonary disease	8.87e-05	0.000467	CcSEcCtD
Venlafaxine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	8.86e-05	0.000467	CcSEcCtD
Venlafaxine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	8.84e-05	0.000466	CcSEcCtD
Venlafaxine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	8.84e-05	0.000466	CcSEcCtD
Venlafaxine—Face oedema—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.000465	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	8.82e-05	0.000464	CcSEcCtD
Venlafaxine—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.79e-05	0.0019	CbGpPWpGaD
Venlafaxine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	8.75e-05	0.000461	CcSEcCtD
Venlafaxine—Irritability—Prednisone—chronic obstructive pulmonary disease	8.73e-05	0.00046	CcSEcCtD
Venlafaxine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	8.71e-05	0.000458	CcSEcCtD
Venlafaxine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	8.7e-05	0.000458	CcSEcCtD
Venlafaxine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.67e-05	0.00187	CbGpPWpGaD
Venlafaxine—Mood swings—Prednisone—chronic obstructive pulmonary disease	8.66e-05	0.000456	CcSEcCtD
Venlafaxine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.59e-05	0.00186	CbGpPWpGaD
Venlafaxine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	8.57e-05	0.000451	CcSEcCtD
Venlafaxine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.55e-05	0.00185	CbGpPWpGaD
Venlafaxine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	8.53e-05	0.000449	CcSEcCtD
Venlafaxine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	8.53e-05	0.000449	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	8.5e-05	0.00184	CbGpPWpGaD
Venlafaxine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.48e-05	0.00183	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	8.42e-05	0.000443	CcSEcCtD
Venlafaxine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	8.42e-05	0.000443	CcSEcCtD
Venlafaxine—Nausea—Tiotropium—chronic obstructive pulmonary disease	8.41e-05	0.000443	CcSEcCtD
Venlafaxine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	8.39e-05	0.000442	CcSEcCtD
Venlafaxine—Dry skin—Prednisone—chronic obstructive pulmonary disease	8.38e-05	0.000441	CcSEcCtD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	8.35e-05	0.0018	CbGpPWpGaD
Venlafaxine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000438	CcSEcCtD
Venlafaxine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	8.24e-05	0.000434	CcSEcCtD
Venlafaxine—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.19e-05	0.000432	CcSEcCtD
Venlafaxine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.19e-05	0.000432	CcSEcCtD
Venlafaxine—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.08e-05	0.000426	CcSEcCtD
Venlafaxine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.08e-05	0.000426	CcSEcCtD
Venlafaxine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000425	CcSEcCtD
Venlafaxine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000425	CcSEcCtD
Venlafaxine—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.03e-05	0.000423	CcSEcCtD
Venlafaxine—SLC6A4—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	8.02e-05	0.00173	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.98e-05	0.00172	CbGpPWpGaD
Venlafaxine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	7.96e-05	0.000419	CcSEcCtD
Venlafaxine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	7.95e-05	0.000418	CcSEcCtD
Venlafaxine—Pruritus—Montelukast—chronic obstructive pulmonary disease	7.92e-05	0.000417	CcSEcCtD
Venlafaxine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	7.81e-05	0.000412	CcSEcCtD
Venlafaxine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	7.81e-05	0.000412	CcSEcCtD
Venlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.8e-05	0.00169	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	7.79e-05	0.00168	CbGpPWpGaD
Venlafaxine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	7.78e-05	0.00041	CcSEcCtD
Venlafaxine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000408	CcSEcCtD
Venlafaxine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	7.74e-05	0.000407	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.72e-05	0.00167	CbGpPWpGaD
Venlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.7e-05	0.00166	CbGpPWpGaD
Venlafaxine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	7.65e-05	0.000403	CcSEcCtD
Venlafaxine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.64e-05	0.00165	CbGpPWpGaD
Venlafaxine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	7.63e-05	0.000402	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.59e-05	0.00164	CbGpPWpGaD
Venlafaxine—Erythema—Prednisolone—chronic obstructive pulmonary disease	7.58e-05	0.000399	CcSEcCtD
Venlafaxine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	7.55e-05	0.000398	CcSEcCtD
Venlafaxine—Dizziness—Formoterol—chronic obstructive pulmonary disease	7.55e-05	0.000398	CcSEcCtD
Venlafaxine—SLC6A4—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	7.47e-05	0.00161	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	7.44e-05	0.00161	CbGpPWpGaD
Venlafaxine—Dizziness—Montelukast—chronic obstructive pulmonary disease	7.4e-05	0.00039	CcSEcCtD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	7.4e-05	0.0016	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.39e-05	0.0016	CbGpPWpGaD
Venlafaxine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	7.39e-05	0.000389	CcSEcCtD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	7.39e-05	0.0016	CbGpPWpGaD
Venlafaxine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	7.38e-05	0.000389	CcSEcCtD
Venlafaxine—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.29e-05	0.00158	CbGpPWpGaD
Venlafaxine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	7.28e-05	0.000383	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.27e-05	0.00157	CbGpPWpGaD
Venlafaxine—Vomiting—Formoterol—chronic obstructive pulmonary disease	7.26e-05	0.000382	CcSEcCtD
Venlafaxine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	7.26e-05	0.000382	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.26e-05	0.00157	CbGpPWpGaD
Venlafaxine—Rash—Formoterol—chronic obstructive pulmonary disease	7.2e-05	0.000379	CcSEcCtD
Venlafaxine—Rash—Arformoterol—chronic obstructive pulmonary disease	7.2e-05	0.000379	CcSEcCtD
Venlafaxine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	7.2e-05	0.000379	CcSEcCtD
Venlafaxine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	7.2e-05	0.000379	CcSEcCtD
Venlafaxine—Weight increased—Prednisone—chronic obstructive pulmonary disease	7.19e-05	0.000379	CcSEcCtD
Venlafaxine—Headache—Arformoterol—chronic obstructive pulmonary disease	7.16e-05	0.000377	CcSEcCtD
Venlafaxine—Headache—Formoterol—chronic obstructive pulmonary disease	7.16e-05	0.000377	CcSEcCtD
Venlafaxine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	7.15e-05	0.000377	CcSEcCtD
Venlafaxine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	7.14e-05	0.000376	CcSEcCtD
Venlafaxine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.13e-05	0.000376	CcSEcCtD
Venlafaxine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	7.13e-05	0.000375	CcSEcCtD
Venlafaxine—Vomiting—Montelukast—chronic obstructive pulmonary disease	7.11e-05	0.000375	CcSEcCtD
Venlafaxine—Rash—Montelukast—chronic obstructive pulmonary disease	7.05e-05	0.000371	CcSEcCtD
Venlafaxine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	7.05e-05	0.000371	CcSEcCtD
Venlafaxine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	7.03e-05	0.00037	CcSEcCtD
Venlafaxine—Depression—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.00037	CcSEcCtD
Venlafaxine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.03e-05	0.00152	CbGpPWpGaD
Venlafaxine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.01e-05	0.00152	CbGpPWpGaD
Venlafaxine—Headache—Montelukast—chronic obstructive pulmonary disease	7.01e-05	0.000369	CcSEcCtD
Venlafaxine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.97e-05	0.00151	CbGpPWpGaD
Venlafaxine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	6.95e-05	0.000366	CcSEcCtD
Venlafaxine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	6.93e-05	0.000365	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000364	CcSEcCtD
Venlafaxine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000364	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.9e-05	0.00149	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	6.89e-05	0.00149	CbGpPWpGaD
Venlafaxine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	6.86e-05	0.000361	CcSEcCtD
Venlafaxine—Malaise—Prednisolone—chronic obstructive pulmonary disease	6.83e-05	0.00036	CcSEcCtD
Venlafaxine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	6.81e-05	0.000359	CcSEcCtD
Venlafaxine—Rash—Salbutamol—chronic obstructive pulmonary disease	6.8e-05	0.000358	CcSEcCtD
Venlafaxine—Syncope—Prednisolone—chronic obstructive pulmonary disease	6.8e-05	0.000358	CcSEcCtD
Venlafaxine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	6.79e-05	0.000358	CcSEcCtD
Venlafaxine—Nausea—Formoterol—chronic obstructive pulmonary disease	6.78e-05	0.000357	CcSEcCtD
Venlafaxine—Nausea—Arformoterol—chronic obstructive pulmonary disease	6.78e-05	0.000357	CcSEcCtD
Venlafaxine—Headache—Salbutamol—chronic obstructive pulmonary disease	6.76e-05	0.000356	CcSEcCtD
Venlafaxine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.72e-05	0.00145	CbGpPWpGaD
Venlafaxine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	6.66e-05	0.000351	CcSEcCtD
Venlafaxine—Nausea—Montelukast—chronic obstructive pulmonary disease	6.65e-05	0.00035	CcSEcCtD
Venlafaxine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.64e-05	0.00144	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.64e-05	0.00144	CbGpPWpGaD
Venlafaxine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	6.57e-05	0.000346	CcSEcCtD
Venlafaxine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	6.54e-05	0.000345	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	6.52e-05	0.00141	CbGpPWpGaD
Venlafaxine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	6.44e-05	0.000339	CcSEcCtD
Venlafaxine—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.41e-05	0.000337	CcSEcCtD
Venlafaxine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	6.38e-05	0.000336	CcSEcCtD
Venlafaxine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.000335	CcSEcCtD
Venlafaxine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.000333	CcSEcCtD
Venlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.32e-05	0.00137	CbGpPWpGaD
Venlafaxine—Hallucination—Prednisone—chronic obstructive pulmonary disease	6.3e-05	0.000331	CcSEcCtD
Venlafaxine—SLC6A4—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	6.29e-05	0.00136	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	6.26e-05	0.00135	CbGpPWpGaD
Venlafaxine—Oedema—Prednisolone—chronic obstructive pulmonary disease	6.19e-05	0.000326	CcSEcCtD
Venlafaxine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	6.19e-05	0.000326	CcSEcCtD
Venlafaxine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.18e-05	0.00134	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.17e-05	0.00133	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.13e-05	0.00132	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.11e-05	0.00132	CbGpPWpGaD
Venlafaxine—Shock—Prednisolone—chronic obstructive pulmonary disease	6.09e-05	0.00032	CcSEcCtD
Venlafaxine—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.08e-05	0.00131	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.06e-05	0.00131	CbGpPWpGaD
Venlafaxine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.04e-05	0.000318	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.03e-05	0.0013	CbGpPWpGaD
Venlafaxine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	5.98e-05	0.000315	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	5.89e-05	0.00127	CbGpPWpGaD
Venlafaxine—Flushing—Prednisone—chronic obstructive pulmonary disease	5.87e-05	0.000309	CcSEcCtD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	5.8e-05	0.00125	CbGpPWpGaD
Venlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.67e-05	0.00123	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.67e-05	0.00122	CbGpPWpGaD
Venlafaxine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	5.65e-05	0.000298	CcSEcCtD
Venlafaxine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	5.59e-05	0.000295	CcSEcCtD
Venlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.59e-05	0.00121	CbGpPWpGaD
Venlafaxine—Alopecia—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000294	CcSEcCtD
Venlafaxine—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.59e-05	0.00121	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.59e-05	0.00121	CbGpPWpGaD
Venlafaxine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	5.55e-05	0.000292	CcSEcCtD
Venlafaxine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.51e-05	0.00119	CbGpPWpGaD
Venlafaxine—Erythema—Prednisone—chronic obstructive pulmonary disease	5.51e-05	0.00029	CcSEcCtD
Venlafaxine—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.37e-05	0.00116	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.31e-05	0.00115	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	5.3e-05	0.00115	CbGpPWpGaD
Venlafaxine—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.3e-05	0.00115	CbGpPWpGaD
Venlafaxine—Pain—Prednisolone—chronic obstructive pulmonary disease	5.29e-05	0.000279	CcSEcCtD
Venlafaxine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	5.19e-05	0.000273	CcSEcCtD
Venlafaxine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.14e-05	0.00111	CbGpPWpGaD
Venlafaxine—SLC6A4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.13e-05	0.00111	CbGpPWpGaD
Venlafaxine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	5.11e-05	0.000269	CcSEcCtD
Venlafaxine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.1e-05	0.000268	CcSEcCtD
Venlafaxine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.09e-05	0.0011	CbGpPWpGaD
Venlafaxine—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000268	CcSEcCtD
Venlafaxine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.07e-05	0.0011	CbGpPWpGaD
Venlafaxine—Agitation—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.000267	CcSEcCtD
Venlafaxine—Angioedema—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000265	CcSEcCtD
Venlafaxine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.02e-05	0.00109	CbGpPWpGaD
Venlafaxine—Malaise—Prednisone—chronic obstructive pulmonary disease	4.97e-05	0.000262	CcSEcCtD
Venlafaxine—Vertigo—Prednisone—chronic obstructive pulmonary disease	4.95e-05	0.000261	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.94e-05	0.00107	CbGpPWpGaD
Venlafaxine—Syncope—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.00026	CcSEcCtD
Venlafaxine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	4.91e-05	0.000259	CcSEcCtD
Venlafaxine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000255	CcSEcCtD
Venlafaxine—Convulsion—Prednisone—chronic obstructive pulmonary disease	4.77e-05	0.000251	CcSEcCtD
Venlafaxine—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.76e-05	0.00025	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.72e-05	0.00102	CbGpPWpGaD
Venlafaxine—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.69e-05	0.000247	CcSEcCtD
Venlafaxine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	4.69e-05	0.000247	CcSEcCtD
Venlafaxine—Anxiety—Prednisone—chronic obstructive pulmonary disease	4.67e-05	0.000246	CcSEcCtD
Venlafaxine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.66e-05	0.00101	CbGpPWpGaD
Venlafaxine—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.63e-05	0.000244	CcSEcCtD
Venlafaxine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.59e-05	0.000993	CbGpPWpGaD
Venlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.59e-05	0.000993	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.56e-05	0.000985	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.56e-05	0.00024	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	4.54e-05	0.000982	CbGpPWpGaD
Venlafaxine—Oedema—Prednisone—chronic obstructive pulmonary disease	4.49e-05	0.000237	CcSEcCtD
Venlafaxine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.49e-05	0.000237	CcSEcCtD
Venlafaxine—Infection—Prednisone—chronic obstructive pulmonary disease	4.47e-05	0.000235	CcSEcCtD
Venlafaxine—Shock—Prednisone—chronic obstructive pulmonary disease	4.42e-05	0.000233	CcSEcCtD
Venlafaxine—SLC6A2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.41e-05	0.000953	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.39e-05	0.00095	CbGpPWpGaD
Venlafaxine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.39e-05	0.000231	CcSEcCtD
Venlafaxine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.35e-05	0.000229	CcSEcCtD
Venlafaxine—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	4.32e-05	0.000934	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.31e-05	0.000931	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.28e-05	0.000926	CbGpPWpGaD
Venlafaxine—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.28e-05	0.000226	CcSEcCtD
Venlafaxine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.28e-05	0.000925	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	4.26e-05	0.00092	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.25e-05	0.000918	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.23e-05	0.000914	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.22e-05	0.000913	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.19e-05	0.000906	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.1e-05	0.000887	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.1e-05	0.000216	CcSEcCtD
Venlafaxine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.09e-05	0.000215	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	4.08e-05	0.000883	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.07e-05	0.000881	CbGpPWpGaD
Venlafaxine—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.07e-05	0.000214	CcSEcCtD
Venlafaxine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.06e-05	0.000877	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.04e-05	0.000874	CbGpPWpGaD
Venlafaxine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.04e-05	0.000213	CcSEcCtD
Venlafaxine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4e-05	0.000865	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4e-05	0.000864	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.99e-05	0.000863	CbGpPWpGaD
Venlafaxine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	3.96e-05	0.000208	CcSEcCtD
Venlafaxine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.94e-05	0.000851	CbGpPWpGaD
Venlafaxine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	3.91e-05	0.000206	CcSEcCtD
Venlafaxine—SLC6A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.91e-05	0.000844	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.9e-05	0.000844	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.9e-05	0.000844	CbGpPWpGaD
Venlafaxine—Rash—Prednisolone—chronic obstructive pulmonary disease	3.9e-05	0.000205	CcSEcCtD
Venlafaxine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	3.9e-05	0.000205	CcSEcCtD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.89e-05	0.000841	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.88e-05	0.000839	CbGpPWpGaD
Venlafaxine—Fatigue—Prednisone—chronic obstructive pulmonary disease	3.88e-05	0.000204	CcSEcCtD
Venlafaxine—Headache—Prednisolone—chronic obstructive pulmonary disease	3.88e-05	0.000204	CcSEcCtD
Venlafaxine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.85e-05	0.000832	CbGpPWpGaD
Venlafaxine—Constipation—Prednisone—chronic obstructive pulmonary disease	3.84e-05	0.000202	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	3.8e-05	0.000821	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.73e-05	0.000807	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.73e-05	0.000806	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.72e-05	0.000804	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.7e-05	0.000195	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.7e-05	0.0008	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.7e-05	0.0008	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.68e-05	0.000796	CbGpPWpGaD
Venlafaxine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.68e-05	0.000194	CcSEcCtD
Venlafaxine—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.67e-05	0.000193	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.66e-05	0.000792	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.65e-05	0.000789	CbGpPWpGaD
Venlafaxine—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.57e-05	0.000188	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.56e-05	0.00077	CbGpPWpGaD
Venlafaxine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.55e-05	0.000187	CcSEcCtD
Venlafaxine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.55e-05	0.000187	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.53e-05	0.000763	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.46e-05	0.000747	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.36e-05	0.000726	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.31e-05	0.000716	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.31e-05	0.000716	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.31e-05	0.000174	CcSEcCtD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.29e-05	0.000712	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.27e-05	0.000707	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.27e-05	0.000706	CbGpPWpGaD
Venlafaxine—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.23e-05	0.00017	CcSEcCtD
Venlafaxine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.19e-05	0.000689	CbGpPWpGaD
Venlafaxine—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.18e-05	0.000167	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.17e-05	0.000686	CbGpPWpGaD
Venlafaxine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.08e-05	0.000162	CcSEcCtD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.03e-05	0.000655	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3e-05	0.000649	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.99e-05	0.000647	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.98e-05	0.000644	CbGpPWpGaD
Venlafaxine—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.97e-05	0.000157	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.96e-05	0.000641	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.86e-05	0.000619	CbGpPWpGaD
Venlafaxine—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.86e-05	0.00015	CcSEcCtD
Venlafaxine—Rash—Prednisone—chronic obstructive pulmonary disease	2.83e-05	0.000149	CcSEcCtD
Venlafaxine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.83e-05	0.000149	CcSEcCtD
Venlafaxine—Headache—Prednisone—chronic obstructive pulmonary disease	2.82e-05	0.000148	CcSEcCtD
Venlafaxine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.8e-05	0.000606	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.78e-05	0.000602	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.76e-05	0.000597	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.72e-05	0.000589	CbGpPWpGaD
Venlafaxine—Nausea—Prednisone—chronic obstructive pulmonary disease	2.67e-05	0.000141	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.6e-05	0.000562	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.59e-05	0.00056	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.57e-05	0.000557	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.54e-05	0.000549	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.48e-05	0.000536	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.44e-05	0.000528	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.41e-05	0.00052	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.33e-05	0.000503	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.23e-05	0.000483	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.2e-05	0.000476	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.16e-05	0.000468	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.14e-05	0.000464	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.12e-05	0.000459	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.11e-05	0.000456	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.1e-05	0.000455	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.09e-05	0.000453	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.08e-05	0.000449	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.05e-05	0.000444	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.05e-05	0.000443	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.99e-05	0.00043	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.99e-05	0.00043	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.98e-05	0.000428	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.97e-05	0.000426	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.96e-05	0.000424	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.96e-05	0.000423	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.96e-05	0.000423	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.94e-05	0.000418	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.92e-05	0.000415	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.91e-05	0.000413	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.87e-05	0.000405	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.82e-05	0.000393	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.8e-05	0.000389	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.79e-05	0.000387	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.78e-05	0.000386	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.72e-05	0.000373	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.71e-05	0.000369	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.64e-05	0.000355	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.64e-05	0.000354	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.61e-05	0.000348	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.57e-05	0.000339	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.56e-05	0.000337	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.54e-05	0.000332	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.52e-05	0.000329	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.5e-05	0.000325	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.46e-05	0.000316	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.44e-05	0.000311	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.42e-05	0.000307	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.42e-05	0.000307	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.37e-05	0.000297	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.35e-05	0.000292	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.32e-05	0.000286	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.3e-05	0.000281	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.29e-05	0.000279	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.27e-05	0.000273	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.26e-05	0.000273	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	0.000271	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.24e-05	0.000267	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.18e-05	0.000254	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.15e-05	0.000248	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.14e-05	0.000246	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.12e-05	0.000243	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.11e-05	0.00024	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000229	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.06e-05	0.000229	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.05e-05	0.000228	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000227	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.05e-05	0.000226	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.04e-05	0.000225	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.04e-05	0.000224	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000224	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.000219	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.83e-06	0.000213	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.69e-06	0.000209	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.66e-06	0.000209	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.55e-06	0.000206	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.54e-06	0.000206	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	9.45e-06	0.000204	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.32e-06	0.000202	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.18e-06	0.000199	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.79e-06	0.00019	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.71e-06	0.000188	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	8.52e-06	0.000184	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	8.15e-06	0.000176	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.97e-06	0.000172	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.86e-06	0.00017	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.78e-06	0.000168	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.67e-06	0.000166	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.33e-06	0.000158	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.32e-06	0.000158	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.26e-06	0.000157	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.23e-06	0.000156	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.16e-06	0.000155	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.15e-06	0.000154	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.94e-06	0.00015	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.91e-06	0.000149	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.83e-06	0.000148	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.77e-06	0.000146	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.73e-06	0.000146	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.68e-06	0.000144	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.38e-06	0.000138	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.33e-06	0.000137	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	6.24e-06	0.000135	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.23e-06	0.000135	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.97e-06	0.000129	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.74e-06	0.000124	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.79e-06	0.000104	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.73e-06	0.000102	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.72e-06	0.000102	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.6e-06	9.95e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.51e-06	9.76e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.4e-06	9.52e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.4e-06	9.52e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.34e-06	9.38e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.3e-06	9.3e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.17e-06	9.02e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.15e-06	8.97e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.11e-06	8.89e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.84e-06	6.13e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.71e-06	5.87e-05	CbGpPWpGaD
